SELLAS Life Sciences (SLS) Is Up 18.0% After Positive AML Trial Updates – What’s Changed

In late 2025, SELLAS Life Sciences Group reported encouraging Phase 2 data for SLS009 in combination with azacitidine and venetoclax in relapsed or refractory acute myeloid leukemia and confirmed that ...

Combination therapy shows promising efficacy in aggressive leukemia

Acute myeloid leukemia (AML) is a particularly aggressive form of blood cancer that usually progresses rapidly if swift and intensive treatment is not applied. Although the disease can often be ...

Woman Loses 70 Pounds in One Month, Then Doctors Discover the Life-Changing Reason Why (Exclusive)

Kennedy Myers has opened up about her cancer journey on TikTok, where she's gained over 134,000 followers talking about her ...